Stephen Paul Jones Selected Research

Abdominal Pain (Pain, Abdominal)

1/2022

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Paul Jones Research Topics

Disease

1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Diarrhea 01/2022
1	Fatigue 01/2022
1	Headache (Headaches) 01/2022
1	Nausea 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022

Drug/Important Bio-Agent (IBA)

1	Donepezil (Aricept)FDA LinkGeneric 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Muscarinic M1 ReceptorIBA 01/2022